CINECA IRIS Institutional Research Information System

PRATESI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.720
EU - Europa 1.549
AS - Asia 432
AF - Africa 159
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.698
IT - Italia 831
SE - Svezia 272
SG - Singapore 169
BG - Bulgaria 146
CI - Costa d'Avorio 127
CN - Cina 118
DE - Germania 90
VN - Vietnam 80
AT - Austria 68
FR - Francia 31
HK - Hong Kong 28
SN - Senegal 26
CH - Svizzera 23
CA - Canada 21
GB - Regno Unito 20
IN - India 20
CZ - Repubblica Ceca 16
PL - Polonia 12
ES - Italia 11
FI - Finlandia 8
RU - Federazione Russa 7
BR - Brasile 5
UA - Ucraina 5
CL - Cile 4
GR - Grecia 4
NG - Nigeria 4
TW - Taiwan 4
EU - Europa 3
JP - Giappone 3
AU - Australia 2
IR - Iran 2
NL - Olanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 4.877
Salva come PNG Salva come JPEG
Città #
Fairfield 437
Woodbridge 274
Milan 243
Ashburn 234
Chandler 193
Seattle 190
Houston 187
Wilmington 165
Cambridge 161
Sofia 146
Abidjan 127
New York 117
Ann Arbor 109
Serra 78
Princeton 76
Beijing 71
Pisa 70
Vienna 62
Bremen 61
Lawrence 58
Medford 52
Singapore 52
Florence 38
Rome 36
Livorno 30
Hong Kong 28
San Diego 27
Dakar 26
Dong Ket 22
Ogden 19
Ottawa 19
Bern 18
Kent 18
Vicopisano 18
Brno 14
Frankfurt am Main 14
Boulder 12
Des Moines 12
Norwalk 10
San Giuliano Terme 10
Trento 10
Cascina 9
London 9
Los Angeles 9
Nanjing 9
Pune 9
Washington 9
Casarza Ligure 8
Jacksonville 8
Marseille 8
Redwood City 7
Arezzo 6
Boardman 6
Fabriano 6
Warsaw 6
Falls Church 5
Ponte San Pietro 5
Anzio 4
Hyderabad 4
Lagos 4
Lubin 4
Lucca 4
Noli 4
Prato 4
Santiago 4
Siracusa 4
Taipei 4
Torino 4
Wuhan 4
Calenzano 3
Campi Bisenzio 3
Chicago 3
Dallas 3
Graz 3
Greve in Chianti 3
Lappeenranta 3
Massa 3
Messina 3
Nanchang 3
Napoli 3
Salerno 3
Sassari 3
Shenyang 3
Tokyo 3
Zurich 3
Amherst 2
Campiglia Marittima 2
Capelle 2
Castelfidardo 2
Chieti 2
Citta 2
Coimbatore 2
Colorado Springs 2
Craco 2
Empoli 2
Gavorrano 2
Hebei 2
Hefei 2
Islington 2
Izmir 2
Totale 3.789
Salva come PNG Salva come JPEG
Nome #
New copper(II)/cyclic tetrapeptide system that easily oxidizes to copper(III) under atmospheric oxygen 185
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 151
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 133
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments 131
Photocytotoxic Pt(iv) complexes as prospective anticancer agents 130
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis 129
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells 119
New gold carbene complexes as candidate anticancer agents 115
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 110
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation 101
Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests 99
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 97
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 93
Ruthenium arene complexes with triphenylphosphane ligands: Cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution 92
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 90
The cisplatin/serum albumin system: A reappraisal 89
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 88
Design and Solid Phase Synthesis of New DOTA Conjugated (+)-Biotin Dimers Planned to Develop Molecular Weight-Tuned Avidin Oligomers 85
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with a L-alanyl-based ligand 84
The NAMI A-human ferritin system: A biophysical characterization 82
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 82
ESI–MS studies of the reactions of novel platinum(II) complexes containing O,O′-chelated acetylacetonate and sulfur ligands with selected model proteins 81
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity 81
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS 75
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 74
Structural Characterization of a Gold/Serum Albumin Complex 71
A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes 71
Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins 71
Impact of ring size on the copper(II) coordination abilities of cyclic tetrapeptides 70
Role of the (pseudo)halido ligand in ruthenium(ii): p -cymene a-amino acid complexes in speciation, protein reactivity and cytotoxicity 69
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 65
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 65
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 65
Alkyne Functionalization of a Photoactivated Ruthenium Polypyridyl Complex for Click-Enabled Serum Albumin Interaction Studies 65
Short-chain oligopeptides with copper(II) binding properties: the impact of specific structural modifications on the copper(II) coordination abilities 63
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 63
Dioxygen oxidation Cu(II) → Cu(III) in the copper complex of cyclo (Lys- d His-βAla-His): A case study by EXAFS and XANES approach 61
Ru(CO)x-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells 61
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study 61
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 61
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 60
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 59
Anticancer diiron vinyliminium complexes: A structure– activity relationship study 58
ESI MS studies highlight the selective interaction of Auranofin with protein free thiols 58
Mass spectrometry and metallomics: stability and binding site location in the Cyt c-CDDP model system 57
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors 56
When ferrocene and diiron organometallics meet: triiron vinyliminium complexes exhibit strong cytotoxicity and cancer cell selectivity 55
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 55
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 53
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs 53
A biophysical study of the interactions of palladium(II), platinum(II) and gold(III) complexes of aminopyridyl-2,2'-bipyridine ligands with RNAs and other nucleic acid structures 52
Iron Binding in the Ferroxidase Site of Human Mitochondrial Ferritin 51
Strategies for the improvement of metal-based chemotherapeutic treatments 51
Computationally enhanced X-ray diffraction analysis of a gold(III) complex interacting with the human telomeric DNA G-quadruplex. Unravelling non-unique ligand positioning 51
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids 50
Mass Spectrometry and Metallomics: binding site location in the Cyt c-CDDP model system 50
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 50
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies 47
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 46
Protein interactions of dirhodium tetraacetate: a structural study 44
Evaluation of Auranofin Loading within Ferritin Nanocages 42
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 41
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 40
Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates 39
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 37
Reactions of medicinal gold(III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods 37
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 36
Structure of a New Stable Cu(III)/Cyclopeptide Complex by Cu K-Edge XAS Study 34
Native mass spectrometry of human carbonic anhydrase I and its inhibitor complexes 34
Structure of a new stable Cu(III)/cyclopeptide complex by Cu K-edge XAS study 31
Is the Next Cisplatin Already in Our Laboratory? 31
Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds 30
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments 26
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex 26
null 25
Direct detection of iron clusters in L ferritins through ESI-MS experiments 25
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 21
Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety 18
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs 13
An unprecedented palladium-arsenic catalytic cycle for nitriles hydration 11
Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity 11
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 10
The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes 4
Exploring the interaction between a fluorescent Ag(I)-biscarbene complex and non-canonical DNA structures: a multi-technique investigation 4
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 3
Editorial: Spotlight on Europe - chemical sciences 2023 1
Totale 5.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.144 43 30 13 218 137 130 126 118 156 66 93 14
2020/2021695 59 19 70 49 26 32 22 50 131 81 51 105
2021/2022724 17 23 11 35 138 111 46 26 72 20 67 158
2022/20231.275 130 120 92 97 73 117 35 59 418 39 48 47
2023/20241.063 115 106 144 77 150 161 71 26 19 22 73 99
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 5.264